American Portfolios Advisors’s Core Laboratories CLB Stock Holding History

American Portfolios Advisors’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$28.9K	Sell	2,145 -264	-11%	-$4.45K	﹤0.01%	2009
2022 Q2	$47.7K	Buy	2,409 +22	+0.9%	+$584	﹤0.01%	1788
2022 Q1	$75.5K	Buy	+2,387	New	+$66.9K	﹤0.01%	1678
2020 Q2	–	Sell	-28	Closed	-$290	–	2851
2020 Q1	$290	Sell	28 -119	-81%	-$3.33K	﹤0.01%	2703
2019 Q4	$5.54K	Sell	147 -30	-17%	-$1.35K	﹤0.01%	2240
2019 Q3	$8.25K	Sell	177 -3	-2%	-$139	﹤0.01%	2002
2019 Q2	$9.41K	Buy	180 +162	+900%	+$9.5K	﹤0.01%	1918
2019 Q1	$1.24K	Buy	18 +1	+6%	+$67	﹤0.01%	2452
2018 Q4	$1.01K	Sell	17 -347	-95%	-$29.9K	﹤0.01%	2255
2018 Q3	$42.2K	Buy	364 +345	+1,816%	+$38.9K	﹤0.01%	1186
2018 Q2	$2.4K	Hold	19	–	–	﹤0.01%	2168
2018 Q1	$2.06K	Sell	19 -2	-10%	-$221	﹤0.01%	2100
2017 Q4	$2.3K	Buy	+21	New	+$2.1K	﹤0.01%	2023

Other funds holding CLB

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

American Portfolios Advisors's CLB Position: Q3 2022 in Review

American Portfolios Advisors reduced its Core Laboratories (CLB) stake by 11% in Q3 2022, selling an estimated $4.45K and leaving 2,145 shares worth $28.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2009.

American Portfolios Advisors first reported a position in CLB in Q4 2017 and has held it in 13 quarters since. The position peaked at $75.5K in Q1 2022. 162 funds tracked by Wall St. Rank hold CLB as of Q3 2022.

American Portfolios Advisors held 2,145 shares of Core Laboratories worth $28.9K as of Q3 2022.
American Portfolios Advisors sold 264 Core Laboratories shares in Q3 2022, an estimated $4.45K.
Core Laboratories made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #2009 holding.
American Portfolios Advisors first reported a position in Core Laboratories in Q4 2017 and has held it in 13 quarters since.
American Portfolios Advisors's Core Laboratories position peaked at $75.5K in Q1 2022.
162 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.